Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Indacaterol vs Salmeterol in Moderate to Severe Persistent Asthma
NCT00529529Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of indacaterol in asthma, sponsored by Novartis. Started Sep 2007; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00529529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529529.